Market capitalization | €84.34m |
Enterprise Value | €91.97m |
P/E (TTM) P/E ratio | 0.69 |
EV/FCF (TTM) EV/FCF | negative |
EV/Sales (TTM) EV/Sales | 3,065.78 |
P/S ratio (TTM) P/S ratio | 2,811.44 |
P/B ratio (TTM) P/B ratio | 0.25 |
Dividend yield | 6.23% |
Last dividend (FY24) | €1.20 |
As a Free StocksGuide user, you can view scores for all 6,823 stocks worldwide.
1 Analyst has issued a forecast MPH Health Care:
1 Analyst has issued a forecast MPH Health Care:
Jun '24 |
+/-
%
|
||
Revenue | 0.03 0.03 |
0%
0%
|
|
Gross Profit | - - |
-
|
|
EBITDA | -1.07 -1.07 |
7%
7%
|
EBIT (Operating Income) EBIT | -1.09 -1.09 |
7%
7%
|
Net Profit | 119 119 |
140%
140%
|
In millions EUR.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
MPH Health Care AG is an investment company, which engages in the acquisition and development of companies and shares in companies from the healthcare industry. It focuses on the market of patent-free and patent-protected pharmaceuticals. The company was founded on November 11, 2008 and is headquartered in Berlin, Germany.
Head office | Germany |
CEO | Patrick Brenske |
Employees | 2 |
Founded | 2008 |
Website | www.mph-ag.de |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.